A review of paresthesia in association with administration of local anesthesia

Dentistry Today

Volumn 22, Issue 2, 2003, Pages 64-69

  Dower Jr , James S ^a  

^a Univ of the Pacific's Sch of Dent

Author keywords

[No Author keywords available]

Indexed keywords

ARTICAINE; BUPIVACAINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; MEPIVACAINE; PRILOCAINE;

AGEUSIA; ANESTHESIA COMPLICATION; BURNING SENSATION; CLINICAL FEATURE; DATA ANALYSIS; DENTAL ANESTHESIA; FREQUENCY ANALYSIS; HUMAN; HYPERSALIVATION; INFERIOR ALVEOLAR NERVE; INTRAVENOUS ANESTHESIA; LINGUAL NERVE; LOCAL ANESTHESIA; MANDIBULAR NERVE; PARESTHESIA; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; SKIN TINGLING; SPEECH DISORDER; TONGUE DISEASE; UNITED STATES; CHEMICALLY INDUCED DISORDER; DRUG EFFECT;

ANESTHESIA, DENTAL; ANESTHETICS, LOCAL; BUPIVACAINE; CARTICAINE; HUMANS; LIDOCAINE; LINGUAL NERVE; MANDIBULAR NERVE; MEPIVACAINE; PARESTHESIA; PRILOCAINE;

EID: 0037315477     PISSN: 87502186     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Malamed SF. Handbook of Local Anesthesia. 4the ed. St. Louis, Mo: C.V. Mosby Co; 1997: 248;249;63-64.
2. Jastak JT, Yagiela JA, Donaldson D. Local Anesthesia of the Oral Cavity. Philadelphia, Pa: W.B. Saunders Co; 1995:301.
3. Haas DA. Localized complications from local anesthesia. J Calif Dent. 1998;26:677-682.
4. Haas DA, Lennon D. A 21-year retrospective study of reports of paresthesia following local anesthetic administration. J Can Dent Assoc. 1995;61:319-330.
5. Pogrel MA, Kaban LB. Injuries to the inferior alveolar and lingual nerves. J Calif Dent. 1993;21:50-4.
6. Pogrel MA, Bryan J, Regezi J. Nerve damage associated with inferior alveolar nerve blocks. J Am Dent Assoc. 1995;126:1150-1155.
7. Pogrel MA, Thamby S. Permanent nerve involvement resulting from inferior alveolar nerve blocks. J Am Dent Assoc. 2000;131:901-907.
8. Harn SD, Durham TM. Incidence of lingual nerve trauma and postinjection complications in conventional mandibular block anesthesia. J Am Dent Assoc. 1990;121:519-523.
9. Kalichman MW, Moorhouse DF, Powell HC, Myers RR. Relative neural toxicity of local anesthetics. J Neuropathol Exp Neurol. 1993;52:234-240.
10. Miller PA, Haas DA. Incidence of local anesthetic-induced neuropathies in Ontario in 1994. J Dent Res. 1996;75SI:247.
11. Miller PA, Haas DA. Incidence of local anesthetic-induced neuropathies in Ontario from 1994-1998. J Dent Res. 2000;79SI:627.
12. Clinical Research Associates Newsletter. 2001;25(6):1-2.
13. Septodont application to United States Food and Drug Administration for approval of articaine local anesthetic (NDA 20-971). 1998;256-259.
14. Septocaine (articaine hydrochloride 4% (40 mg/ml) with epinephrine 1:100,000 injection) product insert 04/2000.
15. Malamed SF, Gagnon S, Leblanc D. Efficacy of articaine: a new amide local anesthetic. J Am Dent Assoc. 2000;131:635-642.
16. Malamed SF, Gagnon S, Leblanc D. Articaine hydrochloride: a study of the safety of a new amide local anesthetic. J Am Dent Assoc. 2001;132:177-184.
17. Pogrel MA, Thamby S. The etiology of altered sensation in the inferior alveolar, lingual, and mental nerves as a result of dental treatment. J Calif Dent. 1999;27:531-538.
18. Supreme Court of Ontario. Trial proceedings No. 158/89; Vol 3:494-497,1989.